This Week in Physical Medicine & Rehabilitation — Aug 6, 2026

Welcome to This Week in Physical Medicine and Rehabilitation. This week we're covering 10 notable papers spanning neurorehabilitation after stroke and Parkinson's disease, spinal cord injury outcomes and communication, and measurement questions in musculoskeletal and multiple sclerosis care. Let's dive in.

We'll start with stroke, where two papers address opposite ends of the care pathway: detecting a hidden impairment, and sustaining a hard-won gain. In Clinical Rehabilitation, an international Delphi process tackled post-stroke spatial neglect, an impairment that is routinely missed and strongly predicts poor functional outcome [1]. Experts from fifteen countries and six disciplines worked through five survey rounds, and they agreed on two things clearly: every stroke survivor should be screened for spatial neglect within two weeks of stroke, and anyone screening positive should go on to a comprehensive assessment covering all neglect subtypes, not just the classic visual-spatial variety. Several tools reached consensus, with shortlists for the remaining subtypes. The honest caveat, which the authors state themselves, is attrition — sixty-six experts started, twenty-nine finished the final round, and only nine attended the consensus meeting, so the tool-specific recommendations rest on a narrower base than the screening recommendation does. Still, if your unit has no systematic neglect screen in the first fortnight, this is a concrete, low-cost gap to close. Then, in the Archives of Physical Medicine and Rehabilitation, a secondary analysis of the DOSE trial asked whether cramming more walking practice into inpatient rehabilitation translates into a more active life a year later [10]. Patients admitted within ten weeks of stroke received either usual therapy, four weeks of structured progressive walking and aerobic exercise at five hours a week, or a double dose at ten hours a week. At twelve months there was no difference in daily step counts between the groups. What did predict twelve-month activity was how much a patient's six-minute walk distance improved during that inpatient month — roughly sixteen extra steps per day for every additional metre gained. The message is nuanced: capacity built in rehabilitation does carry forward, but simply adding therapy hours in hospital does not by itself change long-term behaviour. Sustaining activity likely needs community-phase support, not just a bigger inpatient dose.

Two papers this week address Parkinson's disease, and together they make the case that rehabilitation and technology can each approach the effect of pharmacology. In the Journal of Rehabilitation Medicine, an open randomised trial enrolled patients starting device-aided therapy for advanced Parkinson's disease and gave half of them three months of tailored primary care rehabilitation on top of standard care [2]. Forty-five of fifty-four patients completed the study. Those receiving rehabilitation maintained their motor and process skills better at both six and twelve months, and reported better perceived health. Among the many secondary outcomes, most disease-specific scales showed non-significant improvements, and motor fluctuations improved in both arms — so this is a modest signal, not a sweeping one. An apparent cognitive advantage at twelve months is interesting but needs confirmation. The practical point is that starting a pump or deep brain stimulation is a rehabilitation opportunity, not just a neurology event. Complementing that, the Journal of NeuroEngineering and Rehabilitation reports on a sensor-equipped insole that delivers discreet vibratory feedback the moment stride length shortens or heel strike angle flattens [3]. Thirty-three people with Parkinson's disease walked a seven-hundred-and-thirty-metre course. Both stride length and heel strike angle improved with feedback, and the magnitude was, on average, close to the effect of dopaminergic medication in the fourteen patients tested both off and on medication. Critically, in the second cohort, vibration delivered at random time points produced only intermediate, non-significant changes — so it is the closed-loop, context-appropriate timing that matters, not vibration per se. Gait variability also fell, and participants rated the device as useful. This is a within-session laboratory result, not a durability trial, but it is a credible proof of concept for wearable cueing between physiotherapy visits.

Turning to spinal cord injury, three papers from the Journal of Spinal Cord Medicine converge on a theme of prognosis and function. The first is a prospective Spanish cohort of three hundred and sixty-nine patients aged sixty-five and older with traumatic spinal cord injury, three-quarters of them caused by falls [7]. Overall mortality was just over half, with mean estimated survival of about seven and a half years. Older age at injury, anticoagulant therapy, and chronic obstructive pulmonary disease each independently raised mortality risk — chronic obstructive pulmonary disease roughly doubled it — while higher functional independence scores at discharge were associated with better survival. Notably, the life expectancy deficit attributable to the injury shrank with age, from about thirteen years lost in the sixty-five to sixty-nine group to roughly three years in those eighty and over. That functional independence at discharge tracks with survival is a powerful argument for aggressive rehabilitation in older patients who might otherwise be triaged toward conservative care. A second paper in the same journal examined what actually predicts independence in advanced wheelchair skills — ramps, railings, curbs, and the wheelie — in one hundred and fifty inpatients [9]. Older age consistently predicted remaining dependent across all four skills, while greater upper-extremity strength on admission favoured independence for the wheelie and ramp specifically, but not for railing or curb navigation. That specificity is useful: strength training helps for some skills but is not a universal lever, and goal setting should be matched to the task. The third spinal cord injury paper takes on something we rarely study — how we deliver bad news [8]. Twenty-five people with neurologically complete injury received their ambulation prognosis using the structured SPIKES protocol, and were compared with twenty-seven matched controls from other centres. Ninety-four percent of participants wanted prognostic information even if unfavourable, and those in the SPIKES group scored higher on acceptance, fighting spirit, and total coping. People with paraplegia were considerably more likely than those with tetraplegia to want that conversation during acute care. It's a small, non-randomised pilot, but it suggests that how we frame prognosis may itself be a therapeutic act.

Finally, three papers on measurement and non-pharmacological management. Clinical Rehabilitation published a three-arm randomised trial of one hundred and two patients with electrodiagnostically confirmed mild-to-moderate carpal tunnel syndrome, comparing three weeks of home-based nerve gliding exercises, low-load resistance exercise, or no intervention, with shear wave elastography of the median nerve as the primary outcome [4]. Neither exercise programme changed median nerve or tendon stiffness, or nerve cross-sectional area — yet the gliding group reported better symptoms than controls. So the exercises may help, but not by mechanically remodelling the nerve, and elastography is not a useful surrogate endpoint here. Alongside that, PM and R published minimal important change estimates for carpal tunnel patient-reported outcomes across five health systems and over six hundred patients [6]. At nine months, ninety-one percent of surgical patients were satisfied compared with sixty-seven percent of non-operative patients, and the thresholds differed accordingly — for the carpal tunnel release group, about 0.81 points on the Boston symptom scale, 0.66 on the function scale, and about 16 points on the Quick DASH. Those are numbers you can use tomorrow to judge whether a change score actually means anything. And in Disability and Rehabilitation, an umbrella review of forty-six meta-analyses covering two hundred and eighty-seven primary studies looked at multiple sclerosis-related fatigue [5]. Exercise gave the most consistent benefit — aerobic training modest but reliable, resistance and yoga larger but far more heterogeneous. Cognitive behavioural therapy and mindfulness gave small-to-moderate gains, vitamin D was small, and transcranial direct current stimulation showed a substantial short-term effect. The authors are candid that the underlying reviews were of generally low methodological quality, so treat the neuromodulation figure cautiously. The defensible first-line prescription remains structured exercise, ideally paired with a behavioural component.

If you only have time for one paper this week, make it the DOSE secondary analysis in the Archives of Physical Medicine and Rehabilitation [10]. It challenges a widely held assumption that more inpatient therapy hours automatically buy long-term activity, and it reframes where our discharge planning energy should go.

Here are the key takeaways from this week in Physical Medicine and Rehabilitation. First, screen every stroke survivor for spatial neglect within two weeks, and assess all subtypes if the screen is positive. Second, higher inpatient walking dose did not increase step counts a year after stroke, but gains in six-minute walk distance did predict long-term activity — so build capacity in hospital and support behaviour in the community. Third, in Parkinson's disease, adding rehabilitation around device-aided therapy start preserved motor skills, and closed-loop vibratory insole feedback improved gait to a degree approaching medication effects. Fourth, in older adults with traumatic spinal cord injury, functional independence at discharge was associated with better survival — rehabilitation intensity matters even at eighty. And fifth, short-term exercise did not change median nerve stiffness in carpal tunnel syndrome despite symptom improvement, so stop treating elastography as a proxy for clinical benefit.

That's your roundup for This Week in Physical Medicine and Rehabilitation. The full transcript and references are available on the episode page in your AudioScholar library. This is an AI-curated summary — for clinical decisions, always consult primary sources and current guidelines. See you next week.

If this weekly briefing is useful, follow the show in your podcast app so new episodes arrive automatically. And if you have a paper you have been meaning to read, upload the PDF, or paste any link, at audioscholar dot C C. We will turn it into audio like this one, in any of thirty-one languages.

This is an automated summary generated by artificial intelligence, which can make mistakes. Always review the original source materials.